ArticleCancer immunology, immunotherapy : CII2009

A new tyrosinase epitope recognized in the HLA-B*4002 context by CTL from melanoma patients.

Yann Godet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.